Year |
Citation |
Score |
2024 |
Bharucha-Goebel DX, Todd JJ, Saade D, Norato G, Jain M, Lehky T, Bailey RM, Chichester JA, Calcedo R, Armao D, Foley AR, Mohassel P, Tesfaye E, Carlin BP, Seremula B, et al. Intrathecal Gene Therapy for Giant Axonal Neuropathy. The New England Journal of Medicine. 390: 1092-1104. PMID 38507752 DOI: 10.1056/NEJMoa2307952 |
0.523 |
|
2021 |
Armao D, Bouldin TW, Bailey RM, Gray SJ. Extensive rod and cone photoreceptor-cell degeneration in rat models of giant axonal neuropathy: implications for gene therapy of human disease. Ophthalmic Genetics. 1-4. PMID 33955818 DOI: 10.1080/13816810.2021.1923036 |
0.547 |
|
2021 |
Presa M, Bailey RM, Davis C, Murphy T, Cook J, Walls R, Wilpan H, Bogdanik L, Lenk GM, Burgess RW, Gray SJ, Lutz C. AAV9-mediated FIG4 delivery prolongs life span in Charcot Marie Tooth disease type 4J mouse model. The Journal of Clinical Investigation. PMID 33878035 DOI: 10.1172/JCI137159 |
0.599 |
|
2020 |
Bailey RM, Rozenberg A, Gray SJ. Comparison of High-Dose Intracisterna Magna and Lumbar Puncture Intrathecal Delivery of AAV9 in Mice to Treat Neuropathies. Brain Research. 146832. PMID 32289279 DOI: 10.1016/J.Brainres.2020.146832 |
0.539 |
|
2019 |
Armao D, Bouldin TW, Bailey RM, Hooper JE, Bharucha DX, Gray SJ. Advancing the pathologic phenotype of giant axonal neuropathy: early involvement of the ocular lens. Orphanet Journal of Rare Diseases. 14: 27. PMID 30709364 DOI: 10.1186/S13023-018-0957-5 |
0.56 |
|
2019 |
Lutz C, Presa M, Davis C, Cook J, Murphy T, Burgess R, Bailey RM, Gray SJ. Preclinical gene therapy in a mouse model of Charcot-Marie-Tooth disease type 4J Molecular Genetics and Metabolism. 126: S96-S97. DOI: 10.1016/J.Ymgme.2018.12.241 |
0.578 |
|
2019 |
Bailey RM, Presa M, Lutz C, Gray SJ. Development of scAAV9/SUMF1 gene therapy for multiple sulfatase deficiency Molecular Genetics and Metabolism. 126: S27. DOI: 10.1016/J.Ymgme.2018.12.045 |
0.505 |
|
2018 |
Bardai FH, Ordonez DG, Bailey RM, Hamm M, Lewis J, Feany MB. Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics. Plos Biology. 16: e2006265. PMID 30571694 DOI: 10.1371/Journal.Pbio.2006265 |
0.54 |
|
2018 |
Bailey RM, Armao D, Nagabhushan Kalburgi S, Gray SJ. Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy. Molecular Therapy. Methods & Clinical Development. 9: 160-171. PMID 29766026 DOI: 10.1016/J.Omtm.2018.02.005 |
0.594 |
|
2016 |
Armao D, Bailey RM, Bouldin TW, Kim Y, Gray SJ. Erratum to: Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse: implications for human disease. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. PMID 27514609 DOI: 10.1007/S10286-016-0371-9 |
0.535 |
|
2016 |
Armao D, Bailey RM, Bouldin TW, Kim Y, Gray SJ. Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse: implications for human disease. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. PMID 27369358 DOI: 10.1007/S10286-016-0365-7 |
0.553 |
|
2016 |
Bailey RM, Rozenberg A, Toppins C, Gray SJ. 604. Comparison of Intra-Cisterna Magna and Lumbar Puncture Intrathecal Delivery of scAAV9 GeneTherapy for Giant Axonal Neuropathy Molecular Therapy. 24: S239. DOI: 10.1016/S1525-0016(16)33412-8 |
0.562 |
|
2015 |
Hamm M, Bailey R, Shaw G, Yen SH, Lewis J, Giasson BI. Physiologically relevant factors influence tau phosphorylation by leucine-rich repeat kinase 2. Journal of Neuroscience Research. PMID 26123245 DOI: 10.1002/Jnr.23614 |
0.558 |
|
2014 |
Kantor B, Bailey RM, Wimberly K, Kalburgi SN, Gray SJ. Methods for gene transfer to the central nervous system. Advances in Genetics. 87: 125-97. PMID 25311922 DOI: 10.1016/B978-0-12-800149-3.00003-2 |
0.51 |
|
2014 |
Bailey RM, Howard J, Knight J, Sahara N, Dickson DW, Lewis J. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model. Molecular Neurodegeneration. 9: 8. PMID 24428919 DOI: 10.1186/1750-1326-9-8 |
0.561 |
|
2013 |
Bailey RM, Covy JP, Melrose HL, Rousseau L, Watkinson R, Knight J, Miles S, Farrer MJ, Dickson DW, Giasson BI, Lewis J. LRRK2 phosphorylates novel tau epitopes and promotes tauopathy. Acta Neuropathologica. 126: 809-27. PMID 24113872 DOI: 10.1007/S00401-013-1188-4 |
0.531 |
|
2013 |
Perez PD, Hall G, Kimura T, Ren Y, Bailey RM, Lewis J, Febo M, Sahara N. In vivo functional brain mapping in a conditional mouse model of human tauopathy (tauP301L) reveals reduced neural activity in memory formation structures. Molecular Neurodegeneration. 8: 9. PMID 23379588 DOI: 10.1186/1750-1326-8-9 |
0.566 |
|
2012 |
Cannon A, Yang B, Knight J, Farnham IM, Zhang Y, Wuertzer CA, D'Alton S, Lin WL, Castanedes-Casey M, Rousseau L, Scott B, Jurasic M, Howard J, Yu X, Bailey R, et al. Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction. Acta Neuropathologica. 123: 807-23. PMID 22539017 DOI: 10.1007/S00401-012-0979-3 |
0.714 |
|
2012 |
Bailey R, Cannon A, Melrose H, Farrer M, Dickson D, Lewis J. P1-195: LRRK2 modulation of neuropathology in a mouse model of tauopathy Alzheimer's & Dementia. 8: P175-P175. DOI: 10.1016/J.Jalz.2012.05.473 |
0.652 |
|
2011 |
Cannon A, Yang B, Knight J, Farnham M, Zhang Y, Wuertzer C, D'Alton S, Howard J, Lin W, Scott B, Jurasic M, Yu X, Bailey R, Dickson D, Petrucelli L, et al. P3-006: Neurons during early development are highly vulnerable to TDP-43 dysregulation Alzheimer's & Dementia. 7: S517-S517. DOI: 10.1016/J.Jalz.2011.05.1445 |
0.693 |
|
2011 |
Bailey R, Howard J, Knight J, Dickson D, Lewis J. P3-003: Effect of strain background on pathology progression in tau mouse model Alzheimer's & Dementia. 7: S515-S516. DOI: 10.1016/J.Jalz.2011.05.1442 |
0.582 |
|
2007 |
Zhang YJ, Xu YF, Dickey CA, Buratti E, Baralle F, Bailey R, Pickering-Brown S, Dickson D, Petrucelli L. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 10530-4. PMID 17898224 DOI: 10.1523/Jneurosci.3421-07.2007 |
0.312 |
|
2007 |
Dickey CA, Kamal A, Lundgren K, Klosak N, Bailey RM, Dunmore J, Ash P, Shoraka S, Zlatkovic J, Eckman CB, Patterson C, Dickson DW, Nahman NS, Hutton M, Burrows F, et al. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. The Journal of Clinical Investigation. 117: 648-58. PMID 17304350 DOI: 10.1172/Jci29715 |
0.447 |
|
1993 |
Bird SR, Bailey R, Lewis J. Heart rates during competitive orienteering. British Journal of Sports Medicine. 27: 53-7. PMID 8457815 |
0.459 |
|
Show low-probability matches. |